PrimePartners Corporate Finance Holdings Invests in Trendlines Medical Singapore

PPCFH joins Trendlines and B. Braun Singapore as the third investor in the Trendlines Medical Singapore incubator. Under the agreement, PPCFH becomes a minority shareholder in Trendlines Medical Singapore, holding approximately 3.57%, and B. Braun holding approximately 20.00%, with Trendlines being the majority shareholder with approximately 76.43%.

PrimePartners Capital Finance Holdings Director Gerald Ong

PrimePartners Capital Finance Holdings Director Gerald Ong attends Trendlines 7th Annual Showcase in Israel, March 2017.

Commenting on the execution of the agreement, Eric Loh, CEO of Trendlines Medical Singapore said, “Not only will PPCFH’s investment contribute to the financial strength of the Trendlines Medical Singapore incubator, but we welcome the chance to develop our business network in Singapore and the greater Asia-Pacific region with PPCFH’s experience and capabilities. The combined expertise of Trendlines in early-stage investing and incubator management, B. Braun’s worldwide strength in the medical device sector, and PPCFH’s financial know-how make for a great team to begin our operations.”

Gerald Ong, Director of PPCFH, added, “We are very pleased to come on board as investors in the Trendlines Medical Singapore incubator. This is part of our strategy to be more active in supporting the development of earlier stage companies in Singapore. We look forward to the opportunity to share ideas and pool expertise among the collaborating parties and contribute our strengths and knowledge in the Asian financial sector.”

About PrimePartners Corporate Finance Holdings (PPCFH)

PPCFH is the holding company of PrimePartners Corporate Finance Pte. Ltd. (“PPCF”), which is the sponsor for The Trendlines Group Ltd. Among other safeguards to address potential conflicts: (i) none of the directors, management and associates of PPCFH or PPCF will be on the board of directors of Trendlines Medical Singapore, or be involved in the management and day-to-day operations of Trendlines Medical Singapore; and (ii) annual confirmation of sponsor independence and potential conflicts to the Singapore Exchange.